Cargando…

Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections

BACKGROUND: About 90% of drugs fail in clinical development. The question is whether trials fail because of insufficient efficacy of the new treatment, or rather because of poor trial design that is unable to detect the true efficacy. The variance of the measured endpoints is a major, largely undere...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vegvari, Carolin, Cauët, Emilie, Hadjichrysanthou, Christoforos, Lawrence, Emma, Weverling, Gerrit-Jan, de Wolf, Frank, Anderson, Roy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917234/ https://www.ncbi.nlm.nih.gov/pubmed/27332704 http://dx.doi.org/10.1371/journal.pone.0156622

Ejemplares similares

How Can Viral Dynamics Models Inform Endpoint Measures in Clinical Trials of Therapies for Acute Viral Infections?
por: Vegvari, Carolin, et al.
Publicado: (2016)

Understanding the within-host dynamics of influenza A virus: from theory to clinical implications
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2016)

A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers
por: Lawrence, Emma, et al.
Publicado: (2017)

The development of a stochastic mathematical model of Alzheimer’s disease to help improve the design of clinical trials of potential treatments
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2018)

The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer’s disease treatment?
por: Evans, Stephanie, et al.
Publicado: (2018)

The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2020)

Statistical tests for homogeneity of variance for clinical trials and recommendations
por: Zhou, Yuhang, et al.
Publicado: (2023)

Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities
por: Stylianou, Andria, et al.
Publicado: (2017)

Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease
por: Ower, Alison K., et al.
Publicado: (2017)

Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2018)

SARS‐CoV‐2 viral dynamic modeling to inform model selection and timing and efficacy of antiviral therapy
por: Zhang, Shengyuan, et al.
Publicado: (2023)

Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2022)

SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies
por: Beukenhorst, Anna L., et al.
Publicado: (2023)

Defining stopping criteria for ending randomized clinical trials that investigate the interruption of transmission of soil-transmitted helminths employing mass drug administration
por: Werkman, Marleen, et al.
Publicado: (2018)

Models of kleptoparasitism on networks: the effect of population structure on food stealing behaviour
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2017)

An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018)

Comparative assessment of viral dynamic models for SARS‐CoV‐2 for pharmacodynamic assessment in early treatment trials
por: Agyeman, Akosua A., et al.
Publicado: (2022)

Alzheimer's disease progression and risk factors: A standardized comparison between six large data sets
por: Evans, Stephanie, et al.
Publicado: (2019)

Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer’s disease neuropathology
por: Thomas, David X., et al.
Publicado: (2020)

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
por: Anderson, Roy M, et al.
Publicado: (2020)

Human population movement can impede the elimination of soil-transmitted helminth transmission in regions with heterogeneity in mass drug administration coverage and transmission potential between villages: a metapopulation analysis
por: Vegvari, Carolin, et al.
Publicado: (2019)

Multiple analyses in clinical trials: fundamentals for investigators
por: Moyé, Lemuel A
Publicado: (2003)

Clinical Trials.Gov: A Topical Analyses
por: Anand, Vibha, et al.
Publicado: (2017)

The effect of transmission variance on observer placement for source-localization
por: Spinelli, Brunella, et al.
Publicado: (2017)

Reducing sources of variance in experimental procedures in in vitro research
por: Fischer, Igor, et al.
Publicado: (2022)

The ‘breakpoint’ of soil-transmitted helminths with infected human migration
por: Hardwick, Robert J., et al.
Publicado: (2020)

Recurrent interactions can explain the variance in single trial responses
por: Kotekal, Subhodh, et al.
Publicado: (2020)

Maximin design of cluster randomized trials with heterogeneous costs and variances
por: van Breukelen, Gerard J. P., et al.
Publicado: (2021)

COVID-19 spread in the UK: the end of the beginning?
por: Anderson, Roy M, et al.
Publicado: (2020)

Pre-clerkship clinical skills and clinical reasoning course performance: Explaining the variance in clerkship performance: Pre-clerkship predictors of clerkship variance
por: LaRochelle, Jeffrey S., et al.
Publicado: (2016)

Clinical trials registries: is it viable for the inclusion of conduct, performance, analyses and cost of trials?
por: Young, Amanda, et al.
Publicado: (2013)

Interim analyses and stopping rules in cancer clinical trials.
por: Whitehead, J.
Publicado: (1993)

Innovative trial designs and analyses for vaccine clinical development
por: Liu, Mengya, et al.
Publicado: (2021)

Acupuncture for Knee Osteoarthritis: A Systematic Review of Randomized Clinical Trials with Meta-Analyses and Trial Sequential Analyses
por: Tian, Hao, et al.
Publicado: (2022)

Deconvolution of clinical variance in CAR-T cell pharmacology and response
por: Kirouac, Daniel C., et al.
Publicado: (2023)

Upadacitinib pharmacokinetics and exposure‐response analyses of efficacy and safety in psoriatic arthritis patients – Analyses of phase III clinical trials
por: Muensterman, Elena, et al.
Publicado: (2021)

Spatial scales in human movement between reservoirs of infection
por: Hardwick, Robert J., et al.
Publicado: (2021)

Evidence for the Selective Reporting of Analyses and Discrepancies in Clinical Trials: A Systematic Review of Cohort Studies of Clinical Trials
por: Dwan, Kerry, et al.
Publicado: (2014)

Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
por: Overgaard, Rune V., et al.
Publicado: (2021)

A tutorial on sensitivity analyses in clinical trials: the what, why, when and how
por: Thabane, Lehana, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dnjqcdd65l8o0ra6bokp1nftkg